盐酸缬更昔洛韦片在国内上市时间
The trade name is Vancevir, an antiviral drug used to treat patients with acquired immunodeficiency syndrome (AIDS) combined with cytomegalovirus (CMV) retinitis, and to prevent CMV infection in high-risk solid organ transplant patients.
The recommended dose of valganciclovir hydrochloride tablets (valcyte) for the treatment of induction of cytomegalovirus retinitis is 900 mg (two 450 mg tablets) twice daily for 21 days. Maintenance: After induction therapy, or in adult patients with inactive cytomegalovirus retinitis, the recommended dose is 900 mg orally once daily. Because valganciclovir hydrochloride (valcyte) is teratogenic, women should take a pregnancy test before initiating pregnancy and use effective contraception during treatment and for 30 days after treatment; men should use barrier contraception during treatment and for 90 days after treatment.
In May 2001, the US FDA approved the marketing of valganciclovir hydrochloride tablets (valcyte) for clinical use in the treatment of acute retinitis caused by CMV infection in patients with acquired immunodeficiency syndrome. In May 2003, its indications were expanded and valganciclovir hydrochloride tablets (valcyte) is used to prevent and treat secondary CMV infection in organ transplant recipients. On August 11, 2010, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) approved valganciclovir hydrochloride tablets (valcyte) for the treatment of adult kidney transplant patients at high risk for cytomegalovirus (CMV) disease.
As early as 2006, valganciclovir hydrochloride tablets were successfully launched in my country. Patients can buy medicines in regular hospitals with prescriptions issued by doctors, but as the original drug, valganciclovir hydrochloride tablets are relatively expensive in China. According to the editor of Medical Companion Travel, we learned that Roche’s (valcyte) 450mg*60 tablets sell for about RMB 5,500 in Indian pharmacies. Since the exchange rate fluctuates and the price is not fixed, please consult Medical Travel for the specific price.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)